Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program

Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program

Background In previous studies, patient-reported outcomes (PROs) have been shown to improve survival in cancer patients. The aim of the present study was to assess symptoms potentially related to adverse events experienced by cancer outpatients treated by oral anticancer agents (OAAs) using PROs. Me...

Full description

Bibliographic Details
Main Authors: Bastien Collomb, Amélie Dubromel, Anne Gaëlle Caffin, Chloé Herledan, Virginie Larbre, Amandine Baudouin, Ariane Cerutti, Laurence Couturier, Magali Maire, Lionel Karlin, Delphine Maucort-Boulch, Laure Huot, Stéphane Dalle, Emmanuel Bachy, Hervé Ghesquieres, Gilles Salles, Sébastien Couraud, Benoit You, Gilles Freyer, Véronique Trillet-Lenoir, Florence Ranchon, Catherine Rioufol
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Cancers
Subjects:
patient reported outcomes (PROs)
patient reported outcomes measures (PROMs)
ambulatory care
oral anticancer agent (OAA)
Online Access:https://www.mdpi.com/2072-6694/14/3/660

Internet

https://www.mdpi.com/2072-6694/14/3/660

Similar Items